Does not interact with known drug-metabolising enzymes, which reduces the probability of drug-drug interactions, but long-term metabolic consequences of sustained NNMT suppression in humans remain uncharacterised
However, some find absorption issues persist due to digestive factors or medication use
Personalized B12 Doses We know everyones health goals are personal
GLOW Dosing Protocol The standard protocol for GLOW is 2.8 mg per injection: 2 mg GHK-Cu with 400 mcg each of BPC-157 and TB-4
Choosing a Form at FOY: Decision Criteria Our team considers multiple factors when recommending B12 forms
Data was self-reported by 7,520 surveyed NAD+ Injection customers, 4,330 surveyed B12 Injection customers, and 24,800 LDN customers who checked in with their provider between second and third check-in